MarketInOut Stock Screener Log In | Sign Up

LivaNova Plc

NASDAQ • Healthcare • Medical Devices • Quote as of 10/30/2026
LivaNova Plc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization4,350.73 mln
Float54.87 mln
Earnings Date11/04/2026

EPS

3.38
Solid

P / E

23.36
Premium valuation

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.44
Borderline

1-Year Forecast

90.55
Modest upside

Relative Strength

73 / 100
Outperforming

Business Description

LivaNova is a global medical technology company that develops and sells products across two main areas: equipment used during heart surgery, and devices that treat conditions like epilepsy and depression by stimulating the vagus nerve. The company is also working on a new device aimed at treating obstructive sleep apnea. Its customers include hospitals, surgeons, neurologists, and other healthcare professionals across the United States, Europe, and beyond. Founded in 2015 and based in London, LivaNova reaches its customers through its own sales teams as well as third-party distributors and agents.

Key Fundamentals

EPS3.38
P/E23.36
ROE15.75
RPS26.90
ROIC10.46
ROA7.39
Interest Cover5.93
EBITDA, mln208
EV / EBITDA20.94
EV / EBIT30.16
Revenue, mln1,471
EV / Revenue2.97

Quote Details

Last 78.97
Change -2.28 (-2.81%)
Open 81.38
Volume 575,594
Turnover 45,454,660
Average Volume 550,311

Financial Ratios

Pre-Tax Profit Margin7
Leverage Ratio1.99
Current Ratio1.45
Price / Book3.34
Price / Tangible Book13.44
Price / Cash Flow17.42
Price / Free Cash Flow30.13
Debt / Equity0.27
Price / Sales3.03
PEG Ratio0.93

Financial Strength

Altman Z-Score2.37
Piotroski F-Score 7 / 9
Beneish M-Score-2.44
Price to Intrinsic Value2.42
Price to Graham Number3.08
1-Year Target Price90.55
Short Ratio9.21
Short % of Float12.92

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.39% 26 / 100   
1 Month 5.72% 86 / 100   
2 Months -2% 48 / 100   
6 Months 29.46% 92 / 100   
1 Year 48.05% 91 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog